摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide | 1189583-24-1

中文名称
——
中文别名
——
英文名称
1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide
英文别名
1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3,4-d]imidazole-4-carboxamide;2,3-dimethyl-N-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethyl]thieno[3,4-d]imidazole-6-carboxamide
1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide化学式
CAS
1189583-24-1
化学式
C18H20F3N5OS
mdl
——
分子量
411.451
InChiKey
MFSULEZUEMTURP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    93
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUND
    申请人:Mochizuki Michiyo
    公开号:US20110118236A1
    公开(公告)日:2011-05-19
    An object of the present invention is to provide a novel AMPA receptor potentiator. A compound represented by the following formula (I) or a salt thereof: wherein in formula (I) R 1 represents (1) a halogen atom, or (2) cyano group, or the like; Ra and Rb each independently represent a hydrogen atom or C 1-4 alkyl; L represents a bond, or a spacer in which the number of atoms in the main chain is 1 to 8; Ring A represents (1) a non-aromatic carbon ring of 4-8 carbon atoms, or (2) a 4- to 8-membered non-aromatic heterocycle either of which is optionally substituted with 1 or more substituents selected from (a) halogen atoms, and (b) cyano group; and Ar represents a substituted phenyl group, or optionally substituted 5- or 6-membered aromatic heterocyclic group.
    本发明的目的是提供一种新型AMPA受体增强剂。化合物由以下式(I)或其盐所表示:其中在式(I)中,R1表示(1)卤素原子或(2)基等;Ra和Rb各自独立地表示氢原子或C1-4烷基;L表示键或主链中原子数为1至8的间隔物;环A表示(1)4-8个碳原子的非芳香碳环,或(2)4-至8个成员的非芳香杂环,其中任一环均可以选择性地用1个或多个取代基所取代,所述取代基选择自(a)卤素原子和(b)基;Ar表示取代苯基或可选择性取代的5-或6-成员芳香杂环基。
查看更多

同类化合物

沙维拉唑 4H-吡咯并[1,2-a]噻吩并[3,2-D]咪唑 3H-噻吩并[2,3-d]咪唑-5-羧酸 3-甲基-1H-噻吩并[2,3-d]咪唑-2(3h)-酮 2-(氯甲基)-1H-噻吩并[3,4-d]咪唑 1H-噻吩并[3,2-D]咪唑-2(3H)-酮 1H-噻吩并[2,3-d]咪唑,1-乙烯基-(9CI) 1H-噻吩并(3,4-d)咪唑,2-(((5-甲基-2-吡啶基)甲基)亚硫酰基)- 1-甲基-1H-噻吩并[2,3-D]咪唑基-2(3H)-酮 1-乙烯基-1H-噻吩并[2,3-d]咪唑-5-羧酸 1,3-二氢噻吩并[3,4-d]咪唑-2-硫酮 2-(3-Chloro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(3-cyano-1-isopropyl-pyrrolo[3,2-b]pyridin-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid isopropyl ester 2-(5-Methoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-(4-ethoxy-benzyl)-1(3)H-thieno[2,3-d]imidazole 3,4,8-triamino-1H-pyrazolo<3,4-d>thieno<2,3-b>pyridin-7-carbonsaeure-ethylester 1-[2-(5-Methyl-pyridin-2-ylmethanesulfinyl)-3H-thieno[3,4-d]imidazol-6-yl]-ethanone 2-Oxo-2,3-dihydro-4-methyl-1H-thieno<3,4-d>imidazol 2-[4-(2,2,2-trifluoroethyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 1,2-dimethyl-N-{2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethyl}-1H-thieno[3, 4-d]imidazole-4-carboxamide 2-[4-(2,2,3,3,3-pentafluoropropyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3-Fluoro-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-[(3-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole 2-(5-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrobromide 2-(3,5-Dimethyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 6-ethyl-1-methyl-3-(1-methylethoxy)-5-[(thiophen-2-ylcarbonyl)amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylate 1H-thieno[3,4-d]imidazol-2(3H)-one 2-(4-piperidino-3-chloro-2-picolylmercapto)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(3-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride ethyl 2-benzylthio-1-methoxymethyl-1H-thieno<2,3-d>imidazole-5-carboxylate 2-(6-Methyl-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Methoxy-pyridin-2-ylmethylsulfanyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole; hydrochloride 2-(4-Ethoxy-pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole; hydrochloride 2-[(3-methylpyridin-2-yl)methylsulfanyl]-1H-thieno[3,4-d]imidazole Methyl 2-oxo-1,3-dihydrothieno[3,4-d]imidazole-4-carboxylate 2-oxo-2,3-dihydro-4-(δ-N-methylcarbamidobutyl)-1H-thieno<3,4-d>imidazole methyl 2-hexylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate methyl 2-butylthio-4-methylthieno[3,4-d]imidazole-6-carboxylate dimethyl 4-methyl-4H-pyrrolo[3,2-d][1,3]thiazole-2,5-dicarboxylate 2-[4-(2,2,3,3,4,4,4-heptafluorobutyloxy)-2-picolylsulfinyl]-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-(3,5-Dimethyl-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 4,6-Dimethyl-2-(pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Ethoxy-pyridin-2-ylmethanesulfinyl)-1H-thieno[3,4-d]imidazole 2-(4-Methoxy-pyridin-2-ylmethanesulfinyl)-4,6-dimethyl-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid amide 4-phenyl-2-(pyridin-2-ylmethylsulfanyl)-1H-thieno[3,4-d]imidazole 2-bromo-4H-pyrrolo[3,2-d]thiazole-5-carboxylic acid 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-4-(4-methoxyphenyl)-1H-thieno[3,4-d]imidazole